NCT02655016
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02655016
Title A Study of Niraparib Maintenance Treatment in Patients With HRD-Positive Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Tesaro, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | SWE | NOR | ITA | ISR | IRL | GBR | FRA | FIN | ESP | DNK | DEU | CHE | BEL

Facility Status City State Zip Country Details
GSK Investigational Site Tempe Arizona 85284 United States Details
GSK Investigational Site Tucson Arizona 85710 United States Details
GSK Investigational Site Tucson Arizona 85724 United States Details
GSK Investigational Site San Francisco California 94115 United States Details
GSK Investigational Site San Francisco California 94118 United States Details
GSK Investigational Site Santa Rosa California 95403 United States Details
GSK Investigational Site New Haven Connecticut 06510 United States Details
GSK Investigational Site Jacksonville Florida 32224 United States Details
GSK Investigational Site Miami Florida 33136 United States Details
GSK Investigational Site Atlanta Georgia 30342 United States Details
GSK Investigational Site Savannah Georgia 31404 United States Details
GSK Investigational Site Geneva Illinois 60555 United States Details
GSK Investigational Site Indianapolis Indiana 46237 United States Details
GSK Investigational Site Indianapolis Indiana 46260 United States Details
GSK Investigational Site Iowa City Iowa 52242 United States Details
GSK Investigational Site Covington Louisiana 70433 United States Details
GSK Investigational Site New Orleans Louisiana 70121 United States Details
GSK Investigational Site Baltimore Maryland 21215-5271 United States Details
GSK Investigational Site Rockville Maryland 20910 United States Details
GSK Investigational Site Burlington Massachusetts 01805 United States Details
GSK Investigational Site Grand Rapids Michigan 49503 United States Details
GSK Investigational Site Minneapolis Minnesota 55433 United States Details
GSK Investigational Site Springfield Missouri 97477 United States Details
GSK Investigational Site Neptune City New Jersey 07753 United States Details
GSK Investigational Site Harrison New York 10604 United States Details
GSK Investigational Site Mineola New York 11501 United States Details
GSK Investigational Site New York New York 10016 United States Details
GSK Investigational Site Rochester New York 14620 United States Details
GSK Investigational Site Chapel Hill North Carolina 27599-7570 United States Details
GSK Investigational Site Wilmington North Carolina 28401 United States Details
GSK Investigational Site Columbus Ohio 43210 United States Details
GSK Investigational Site Oklahoma City Oklahoma 73104 United States Details
GSK Investigational Site Tulsa Oklahoma 74146 United States Details
GSK Investigational Site Portland Oregon 97210 United States Details
GSK Investigational Site Philadelphia Pennsylvania 19104 United States Details
GSK Investigational Site Willow Grove Pennsylvania 19090 United States Details
GSK Investigational Site Providence Rhode Island 02905 United States Details
GSK Investigational Site Charleston South Carolina 29425 United States Details
GSK Investigational Site Sioux Falls South Dakota 57105 United States Details
GSK Investigational Site Fort Worth Texas 76104 United States Details
GSK Investigational Site The Woodlands Texas 77380 United States Details
GSK Investigational Site Tyler Texas 75701 United States Details
GSK Investigational Site Salt Lake City Utah 84112 United States Details
GSK Investigational Site Kennewick Washington 99336 United States Details
GSK Investigational Site Seattle Washington 98104 United States Details
GSK Investigational Site Spokane Washington 99202 United States Details
GSK Investigational Site Milwaukee Wisconsin 53226 United States Details
GSK Investigational Site Bonheiden 2820 Belgium Details
GSK Investigational Site Brussels 1000 Belgium Details
GSK Investigational Site Brussels 1200 Belgium Details
GSK Investigational Site Ghent 9000 Belgium Details
GSK Investigational Site Hasselt 3500 Belgium Details
GSK Investigational Site Leuven 3000 Belgium Details
GSK Investigational Site Libramont 6800 Belgium Details
GSK Investigational Site Namur 5000 Belgium Details
GSK Investigational Site Aalborg 9000 Denmark Details
GSK Investigational Site Copenhagen 2100 Denmark Details
GSK Investigational Site Herlev 2730 Denmark Details
GSK Investigational Site Odense C 5000 Denmark Details
GSK Investigational Site Kuopio 70210 Finland Details
GSK Investigational Site Oulu 90029 Finland Details
GSK Investigational Site Tampere 33521 Finland Details
GSK Investigational Site Turku 20520 Finland Details
GSK Investigational Site Angers 49000 France Details
GSK Investigational Site Aachen 52074 Germany Details
GSK Investigational Site Berlin 13353 Germany Details
GSK Investigational Site Essen 45136 Germany Details
GSK Investigational Site Fürth 90766 Germany Details
GSK Investigational Site Göttingen 37075 Germany Details
GSK Investigational Site Heidelberg 69120 Germany Details
GSK Investigational Site Hildesheim 31134 Germany Details
GSK Investigational Site Mannheim 68167 Germany Details
GSK Investigational Site München 81377 Germany Details
GSK Investigational Site Dublin 8 Ireland Details
GSK Investigational Site Dunmore RoadWaterford Ireland Details
GSK Investigational Site Galway H91 YR71 Ireland Details
GSK Investigational Site Haifa 38100 Israel Details
GSK Investigational Site Ramat Gan 52621 Israel Details
GSK Investigational Site Tel Aviv 64239 Israel Details
GSK Investigational Site Lecce 73100 Italy Details
GSK Investigational Site Milan 20132 Italy Details
GSK Investigational Site Milan 20133 Italy Details
GSK Investigational Site Modena 41100 Italy Details
GSK Investigational Site Napoli 80131 Italy Details
GSK Investigational Site Oslo 0310 Norway Details
GSK Investigational Site Badalona 08916 Spain Details
GSK Investigational Site Barcelona 08003 Spain Details
GSK Investigational Site Barcelona 08036 Spain Details
GSK Investigational Site Barcelona 08907 Spain Details
GSK Investigational Site Barcelona 8035 Spain Details
GSK Investigational Site Córdoba 14004 Spain Details
GSK Investigational Site Donostia / San Sebastian 20014 Spain Details
GSK Investigational Site Elche Alicante 03203 Spain Details
GSK Investigational Site Girona 17007 Spain Details
GSK Investigational Site Madrid 28033 Spain Details
GSK Investigational Site Madrid 28041 Spain Details
GSK Investigational Site Madrid 28046 Spain Details
GSK Investigational Site Seville 41013 Spain Details
GSK Investigational Site Seville 41014 Spain Details
GSK Investigational Site Valencia 46009 Spain Details
GSK Investigational Site Valencia 46010 Spain Details
GSK Investigational Site Zaragoza 50009 Spain Details
GSK Investigational Site Stockholm SE-171 76 Sweden Details
GSK Investigational Site Uppsala SE-751 85 Sweden Details
GSK Investigational Site Basel 4031 Switzerland Details
GSK Investigational Site Bern 3010 Switzerland Details
GSK Investigational Site Frauenfeld 8501 Switzerland Details
GSK Investigational Site Zurich 8091 Switzerland Details
GSK Investigational Site Blackburn BB2 3HH United Kingdom Details
GSK Investigational Site Edinburgh G12 0YN United Kingdom Details
GSK Investigational Site Exeter EX2 5DW United Kingdom Details
GSK Investigational Site Glasgow G12 0YN United Kingdom Details
GSK Investigational Site London W12 0HS United Kingdom Details
GSK Investigational Site Portsmouth PO6 3LY United Kingdom Details
GSK Investigational Site Sheffield S10 2SJ United Kingdom Details
GSK Investigational Site Truro TR1 3LJ United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field